We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Conor Medsystems presented 12-month follow-up data from its PISCES (Paclitaxel
In-Stent Controlled Elution Study) clinical trial at the American College of
Cardiology scientific session in Orlando, Fla., that supported the long-term
safety and efficacy of Conor's novel cardiovascular stent technology.
Arcturus Bioscience, has announced that Antonius Schuh has been appointed chief
executive officer and will be elected a member of the company's board of directors.
After the leaky mitral valves in their hearts were repaired nonsurgically with
a tiny, catheter-fed clip, nearly all -- over 90 percent -- of the patients whose
mitral regurgitation was significantly reduced one month after receiving the
clip maintained the reduction at six months.
Cambridge Heart announced the completion of enrollment in the MASTER I Clinical
Trial (Microvolt T-Wave AlternanS TEsting for Risk Stratification of Post MI
Patients).
Nanogen, developer of advanced diagnostic products, announced its subsidiary
SynX signed five new European distributors for its point-of-care products.
Delphi Medical Systems, a subsidiary of Delphi, expanded its collaboration with
SRI International, a non-profit public benefit organization, to develop a patented,
respiratory care family of devices for use primarily at home and in alternate
sites.
Fisher Scientific International has signed a definitive agreement to sell Atos
Medical AB, a manufacturer of ear, nose and throat medical devices with 2004
sales totaling $35 million, to Nordic Capital for $110 million in cash.
Abbott announced the availability of a fully automated
hepatitis C virus (HCV) test in the U.S. for its widely-used AxSYM automated
immunoassay instrument system.